ITC Posts 5% Profit Growth and ₹8 Dividend How a Price Hike Strategy Protects a Business From Tax Pressure

Apollo Hospitals shares surged 3.83% to hit a 52-week high of ₹8,388 on NSE after posting strong Q4 FY26 results. The stock gained for three straight sessions a clear signal that investors are rewarding consistent quality growth. Hospitals business → Core hospital network expanding with rising footfalls, higher occupancy and premium services driving revenue per bed higher. Apollo Health and Lifestyle → Diagnostics, clinics and preventive health segment growing 24% tapping India's rising awareness around routine health checkups. Apollo HealthCo → Pharmacy and digital health arm growing 20% benefiting from India's shift toward organised pharmacy retail and online health consultations. Apollo's board approved merging Apollo Hospitals North a wholly owned subsidiary into the parent company. This simplifies the corporate structure, reduces administrative costs and brings all assets under one roof a positive signal for operational efficiency. India is massively underserved in quality healthcare. Rising incomes, growing health insurance penetration and an ageing population create structural demand that does not slow down even during economic uncertainty. Apollo as India's largest private hospital chain sits right at the centre of this multi-decade opportunity. Apollo Hospitals' 33% profit growth and 52week high teaches investors that healthcare companies with multiple revenue streams hospitals, diagnostics, pharmacy and digital health are structurally positioned to grow consistently, and that tracking revenue per segment alongside overall profit growth is essential for understanding which parts of a healthcare business are driving returns before making a long term investment decision. $APOLLOHOSP $MAXHEALTH $FORTIS $NH